BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.92% |
| 2 | Financials | 6.08% |
| 3 | Healthcare | 5.28% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
2851
DELISTED
Allakos
ALLK
| $130K | ﹤0.01% |
3,220
+3,155
| +4,854% | +$128K |
|
|
NSTG
2852
DELISTED
NanoString Technologies, Inc.
NSTG
| $130K | ﹤0.01% |
5,444
+5,436
| +67,950% | +$125K |
|
|
AEGN
2853
DELISTED
Aegion Corp
AEGN
| $130K | ﹤0.01% |
7,413
+4,490
| +154% | +$81.4K |
|
2854
Novartis
NVS
$287B
| $129K | ﹤0.01% |
1,502
| – | – |
|
2855
Integra LifeSciences
IART
$1.43B
| $129K | ﹤0.01% |
2,320
+1,266
| +120% | +$64.5K |
|
2856
John B. Sanfilippo & Son
JBSS
$1.01B
| $129K | ﹤0.01% |
1,797
+1,727
| +2,467% | +$115K |
|
2857
Ecovyst
ECVT
$1.14B
| $128K | ﹤0.01% |
8,465
+6,129
| +262% | +$93.9K |
|
2858
Addus HomeCare
ADUS
$2.17B
| $128K | ﹤0.01% |
2,019
+1,997
| +9,077% | +$128K |
|
|
BGG
2859
DELISTED
Briggs & Stratton Corp.
BGG
| $128K | ﹤0.01% |
10,828
+5,329
| +97% | +$69.3K |
|
2860
VanEck Vietnam ETF
VNM
$496M
| $128K | ﹤0.01% |
7,735
+2,338
| +43% | +$37.7K |
|
2861
Ashland
ASH
$3.38B
| $128K | ﹤0.01% |
1,639
-56,715
| -97% | -$4.37M |
|
2862
Photronics
PLAB
$1.96B
| $128K | ﹤0.01% |
13,545
+7,604
| +128% | +$77K |
|
2863
OneSpan
OSPN
$602M
| $127K | ﹤0.01% |
6,624
+6,272
| +1,782% | +$107K |
|
|
PDLI
2864
DELISTED
PDL BioPharma, Inc.
PDLI
| $127K | ﹤0.01% |
34,205
+29,834
| +683% | +$101K |
|
|
STFC
2865
DELISTED
State Auto Financial Corp
STFC
| $126K | ﹤0.01% |
3,840
+2,849
| +287% | +$96.5K |
|
|
ITCI
2866
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $126K | ﹤0.01% |
10,361
+9,307
| +883% | +$119K |
|
|
NEX
2867
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $126K | ﹤0.01% |
11,585
+10,464
| +933% | +$105K |
|
2868
American Vanguard Corp
AVD
$62.5M
| $126K | ﹤0.01% |
7,325
+5,022
| +218% | +$88.6K |
|
2869
RE/MAX Holdings
RMAX
$268M
| $126K | ﹤0.01% |
3,271
+2,565
| +363% | +$98.3K |
|
2870
Viking Therapeutics
VKTX
$3.87B
| $126K | ﹤0.01% |
+12,681
| New | +$106K |
|
2871
Aecom
ACM
$8.12B
| $126K | ﹤0.01% |
4,245
+1,723
| +68% | +$51.5K |
|
|
EXTN
2872
DELISTED
Exterran Corporation
EXTN
| $126K | ﹤0.01% |
7,469
+4,814
| +181% | +$85.7K |
|
|
PVG
2873
DELISTED
PRETIUM RESOURCES INC.
PVG
| $126K | ﹤0.01% |
14,700
| – | – |
|
2874
NewMarket
NEU
$8.85B
| $126K | ﹤0.01% |
290
+124
| +75% | +$52.4K |
|
2875
StoneX
SNEX
$8.09B
| $126K | ﹤0.01% |
16,418
+12,317
| +300% | +$97.2K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.